|
Variable
|
Odd ratio
|
95% confidence interval
|
p Value
|
|---|
|
Model A
| |
|
MICS vs. Sternotomy CABG
|
0.44
|
0.24–0.78
|
0.005
|
|
Internal mammary artery used
|
0.39
|
0.17–0.89
|
0.02
|
|
Postoperative new onset atrial fibrillation
|
1.72
|
1.01–2.93
|
0.04
|
|
Beta blockers on discharge
|
0.57
|
0.30–1.09
|
0.09
|
|
In-hospital clopidogrel
|
1.56
|
0.92–2.63
|
0.09
|
|
Model B
| |
|
MICS vs. Sternotomy CABG
|
0.50
|
0.28–0.90
|
0.02
|
|
Age (per year)
|
1.08
|
1.05–1.11
|
<0.001
|
|
Preoperative renal failure on dialysis
|
10.05
|
3.46–29.19
|
<0.001
|
|
Internal mammary artery used
|
0.48
|
0.20–1.12
|
0.08
|
- Model A included history of prior coronary angioplasty, MICS vs. sternotomy CABG, postoperative new onset atrial fibrillation, use of internal mammary artery, use of cardiopulmonary bypass, clopidogrel on discharge and in-hospital, coumadin on discharge, beta blockers on discharge.
- Model B included age, gender, family history of coronary artery disease, history of renal dialysis, statin on discharge, coumadin on discharge, use of internal mammary artery, MICS vs. sternotomy CABG and postoperative new onset atrial fibrillation.
-
MICS minimal invasive cardiac surgery (thoracotomy), CABG coronary artery bypass graft.
